The Governors of the University of Calgary
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1966-04-29
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.ucalgary.ca
IV Fluids and Post-ERCP Pancreatitis
Recruiting
- Conditions
- ERCP
- Interventions
- Other: IV fluids
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 13000
- Registration Number
- NCT05211206
- Locations
- 🇨🇦
Peter Lougheed Hospital, Calgary, Alberta, Canada
Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury
Phase 1
Recruiting
- Conditions
- Osteo Arthritis KneeAnterior Cruciate Ligament TearAnterior Cruciate Ligament InjuriesAnterior Cruciate Ligament Rupture
- Interventions
- Drug: Zoledronic Acid InjectionDrug: Placebo
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 56
- Registration Number
- NCT05204836
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
A Culinary Intervention for Bone Health
Not Applicable
Completed
- Conditions
- Osteoporosis, Age-RelatedOsteoporosis Risk
- Interventions
- Behavioral: Culinary Medicine Intervention
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 40
- Registration Number
- NCT05197244
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
iTBS-DCS in Obsessive Compulsive Disorder
Phase 2
Active, not recruiting
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Device: iTBS repetitive Transcranial Magnetic Stimulation (rTMS)Device: Sham rTMSDrug: Placebo oral capsuleDrug: D-cycloserine
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 81
- Registration Number
- NCT05177601
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Study of Atomoxetine in the Prevention of Vasovagal Syncope
Phase 3
Recruiting
- Conditions
- Vasovagal Syncope
- Interventions
- Drug: Atomoxetine HydrochlorideDrug: Placebo
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 180
- Registration Number
- NCT05159687
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Optimizing the Evaluation and Management of Patients With Suspected Choledocholithiasis
Recruiting
- Conditions
- CholedocholithiasisBiliary Disease
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 2000
- Registration Number
- NCT05141916
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
The Need for Repeat ERCP After Endoscopic Treatment of Postsurgical Biliary Leaks
Recruiting
- Conditions
- Bile Leak
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 200
- Registration Number
- NCT05141942
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
BREATHE: Virtual Self-management for Long COVID-19
Not Applicable
Completed
- Conditions
- COVID-19
- Interventions
- Other: BREATHE
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 27
- Registration Number
- NCT05107440
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Robotic Evaluations of Motor Learning During Stroke Neurorehabilitation
Recruiting
- Conditions
- Stroke
- Interventions
- Other: Magnetic Resonance Imaging (MRI)Other: Clinical AssessmentDevice: Kinarm Robotic Exoskeleton Assessment
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 300
- Registration Number
- NCT05106140
- Locations
- 🇨🇦
Carewest Dr. Vernon Fanning Centre, Calgary, Alberta, Canada
🇨🇦University of Calgary - Kinesiology Building, Calgary, Alberta, Canada
🇨🇦Foothills Hospital - Main Building, Calgary, Alberta, Canada
A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
Phase 3
Active, not recruiting
- Conditions
- Migraine Disorders
- Interventions
- Device: Active Remote Electrical Neuromodulation DeviceDrug: KetorolacDrug: PlaceboDrug: MetoclopramideDevice: Sham Remote Electrical Neuromodulation Device
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 22
- Registration Number
- NCT05102591
- Locations
- 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath